Company / PP&E (Net)
Maze Therapeutics, Inc. PP&E (Net) History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$5.0M
FY2025
5-year range
$5.0M / $5.0M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#112 of 193
Health Care
What the data says
At $5M, Maze Therapeutics, Inc.'s pp&e (net) ranks #112 of 193 in the Health Care sector.
Based on SEC 10-K filings.
$5M in FY2025.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#112 of 193 in Health CareTop 58% of 193This company $5.0M Sector average $777.6M
▼
-99.4% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.0M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026